Even an endogenous or short peptide can cause harm when the route, exposure, or manufacturing quality changes
For patients experiencing reflux symptoms during GLP-1 treatment, several evidence-based management strategies can help minimize discomfort while maintaining therapeutic benefits
If you become pregnant unexpectedly while taking a GLP-1 drug, informing your obstetrician immediately allows them to monitor for any potential risks specific to your situation
Very insightful.
Proper laboratory handling procedures are recommended to maintain sterility and overall product quality after opening
PLoS One 7(2):e32008 Mohiuddin MS, Himeno T, Inoue R, Miura-Yura E, Yamada Y, Nakai-Shimoda H, Asano S, Kato M, Motegi M, Kondo M, Seino Y (2019) Glucagon-like Peptide-1 receptor agonist protects dorsal root ganglion neurons against oxidative insult